Manton Center for Orphan Disease Research

Manton Center for Orphan Disease Research
Name	Manton Center for Orphan Disease Research
Established	2008
Parent organization	Boston Children's Hospital
Affiliation	Harvard Medical School
Director	Alan H. Beggs, Ph.D.
Location	Boston, Massachusetts, United States

Manton Center for Orphan Disease Research is a dedicated research institute within Boston Children's Hospital focused on the study of rare genetic disorders. Established through a transformative philanthropic gift, it operates in close affiliation with Harvard Medical School to advance the understanding, diagnosis, and treatment of conditions that affect small patient populations. The center serves as a collaborative hub, uniting clinicians, scientists, and families to tackle the unique challenges of orphan diseases.

History and establishment

The center was founded in 2008 following a historic $25 million gift from Sir Edmund Manton and Lady Catherine Manton of the American Friends of the Royal Academy. This donation, one of the largest single gifts in the history of Boston Children's Hospital, was specifically earmarked to create a world-leading institution for rare disease research. The establishment of the center addressed a critical gap in biomedical research, where common diseases often received disproportionate funding and attention. Its creation was championed by hospital leadership and researchers like Alan H. Beggs, who recognized the profound unmet need for patients with rare conditions across New England and globally.

Mission and focus

The core mission is to accelerate the discovery of causes and cures for rare genetic diseases, often termed orphan diseases, which individually affect fewer than 200,000 people in the United States but collectively impact millions. Its focus extends across the entire spectrum of rare disease research, from basic genomics and molecular biology to clinical translation and therapeutic development. A central tenet of its work is a deeply patient-centric approach, actively engaging with families and advocacy groups like the National Organization for Rare Disorders to ensure research addresses direct patient needs. The center prioritizes conditions with little commercial research incentive, thereby filling a vital role in the global biomedical ecosystem.

Research programs and initiatives

Key programs include the **Gene Discovery Core**, which utilizes advanced techniques like whole-exome sequencing and whole-genome sequencing to identify novel disease-causing mutations. The **Undiagnosed Diseases Network** site at Boston Children's Hospital is integrally connected to the center's efforts to solve the most perplexing medical mysteries. Initiatives such as the **Manton Center Family Partnership Program** directly integrate patient families into the research process. The center also fosters translational research through collaborations with entities like the Broad Institute of MIT and Harvard and the Harvard Stem Cell Institute, aiming to move discoveries from the laboratory bench toward clinical trials.

Key discoveries and impact

Researchers affiliated with the center have identified genetic causes for numerous previously undefined syndromes, leading to the first published diagnoses for families after years of uncertainty. Work on specific disorders, such as congenital myasthenic syndromes and various rare neuropathies, has directly informed new treatment protocols and therapeutic strategies. These discoveries have been disseminated in high-impact journals including The New England Journal of Medicine and Nature Genetics. The center's impact is measured not only in publications but in its profound influence on the clinical care landscape at Boston Children's Hospital and its role in shaping national research agendas through participation in consortia like the NIH's **Rare Diseases Clinical Research Network**.

Organizational structure and leadership

The center is an integral part of the Boston Children's Hospital research enterprise and is closely allied with the Division of Genetics and Genomics. It is directed by **Alan H. Beggs, Ph.D.**, a renowned geneticist and the Sir Edwin and Lady Manton Professor of Pediatrics at Harvard Medical School. Scientific oversight is provided by an executive committee composed of senior faculty from diverse disciplines. The center operates as an interdisciplinary nexus, supporting principal investigators and their laboratories while also providing pilot funding and core resources to catalyze new projects across the hospital and the wider Harvard University community.

Funding and partnerships

Initial endowment from the Manton Foundation provides sustained core support, which is leveraged to attract competitive grants from the National Institutes of Health, the Howard Hughes Medical Institute, and private foundations such as the March of Dimes. Critical partnerships extend to biopharmaceutical companies through tailored research agreements focused on orphan drug development. The center also maintains strong collaborative ties with patient advocacy organizations, which often provide both funding and essential clinical insights. These multifaceted funding streams and alliances ensure the center's longevity and its ability to pursue high-risk, high-reward science.

Category:Medical research institutes in the United States Category:Boston Children's Hospital Category:Rare diseases Category:Organizations established in 2008 Category:Harvard Medical School